Zhoujun Lin

Nankai University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

8h-index207citations19works3.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer, Hypoxia, and Metabolism(5), PI3K/AKT/mTOR signaling in cancer(4), Cancer Cells and Metastasis(3), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(3), Pancreatic and Hepatic Oncology Research(2)

Publications19 total

Disulfiram activation of prostaglandin E2 synthesis: a novel antifibrotic mechanism in pulmonary fibrosis
Journal of Pharmacology and Experimental Therapeutics·2025
<scp>MCL</scp> restrained <scp>ROS/AKT/ASAH1</scp> pathway to therapy tamoxifen resistance breast cancer by stabilizing <scp>NRF2</scp>
Cell Proliferation·2024· 6 citedOpen Access
Targeting estrogen mediated CYP4F2/CYP4F11-20-HETE metabolic disorder decelerates tumorigenesis in ER+ breast cancer
Biochemistry and Biophysics Reports·2024· 4 citedOpen Access
Glutaredoxin‐1 promotes lymphangioleiomyomatosis progression through inhibiting Bim‐mediated apoptosis via COX2/PGE2/ERK pathway
Clinical and Translational Medicine·2023· 6 citedOpen Access
G6PD activation in TNBC cells induces macrophage recruitment and M2 polarization to promote tumor progression
Cellular and Molecular Life Sciences·2023· 26 citedOpen Access
Disulfiram Exerts anti-pulmonary Fibrosis Effect by Activating PGE2 Synthesis
2023Open Access
Inhibition of Polo-like kinase 1 (PLK1) triggers cell apoptosis via ROS-caused mitochondrial dysfunction in colorectal carcinoma
Journal of Cancer Research and Clinical Oncology·2023· 8 citedOpen Access
The antitumor effect of the novel agent MCL/ACT001 in pancreatic ductal adenocarcinoma
Journal of Cancer Research and Clinical Oncology·2022· 7 citedOpen Access
Targeting SPHK1/S1PR3-regulated S-1-P metabolic disorder triggers autophagic cell death in pulmonary lymphangiomyomatosis (LAM)
Cell Death and Disease·2022· 11 citedOpen Access
Targeting estrogen-mediated CYP4F2/CYP4F11-20-HETE metabolic disorder decelerates tumorigenesis in ER+ breast cancer
Research Square (Research Square)·2022· 1 citedOpen Access
Inhibition of Polo-like kinase 1 (PLK1) triggers cell apoptosis via ROS-caused mitochondrial dysfunction in colorectal carcinoma
Research Square (Research Square)·2022Open Access
Costimulatory and coinhibitory molecules of B7-CD28 family in cardiovascular atherosclerosis: A review
Medicine·2022· 13 citedOpen Access
Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer
International Journal of Molecular Sciences·2022· 20 citedOpen Access
Pyrotinib Targeted EGFR-STAT3/CD24 Loop-Mediated Cell Viability in TSC
Cells·2022· 5 citedOpen Access
The anti-tumor effect of a novel agent MCL/ACT001 in pancreatic ductal adenocarcinoma
Research Square (Research Square)·2022· 1 citedOpen Access
Targeting glucose‐6‐phosphate dehydrogenase by <scp>6‐AN</scp> induces <scp>ROS</scp> ‐mediated autophagic cell death in breast cancer
FEBS Journal·2022· 38 citedOpen Access
Author response for "Targeting glucose‐6‐phosphate dehydrogenase by &lt;scp&gt;6‐AN&lt;/scp&gt; induces &lt;scp&gt;ROS&lt;/scp&gt; ‐mediated autophagic cell death in breast cancer"
2022
Cardiac Toxicity From Adjuvant Targeting Treatment for Breast Cancer Post-Surgery
Frontiers in Oncology·2022· 18 citedOpen Access
Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway
Cells·2022· 43 citedOpen Access

Frequent Co-authors

Xiaolin Pei(14), Chenggang Li(13), Zhenkun Fu(13), Xiao Han(12), Tianjiao Li(10), Ya Feng(9), Fangxu Zheng(6), Changjun Wang(6), Lizhong Yan(5), Yin Li(5), Zhenhuan Tian(4), Yupeng Zhang(4), Chenggang Li(4), Xiao Han(3), Dunqiang Ren(3), Ke Cao(3), Li Ding(3), Qiang Sun(3), Yin Li(3), Yupeng Zhang(3)